|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15-16
|
|
pubmed:dateCreated |
2001-6-12
|
|
pubmed:abstractText |
Germ-line alterations in BRCA1 and BRCA2 genes account for 30-50% of all forms of familial breast and ovarian cancer syndromes. Specific mutations in specific populations and ethnic groups have been identified in BRCA1 and BRCA2. However, it is not known whether such specific mutations prevail in the Swiss population.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1424-7860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
21
|
|
pubmed:volume |
131
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
223-6
|
|
pubmed:dateRevised |
2011-2-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11400546-Adult,
pubmed-meshheading:11400546-BRCA2 Protein,
pubmed-meshheading:11400546-Breast Neoplasms,
pubmed-meshheading:11400546-Female,
pubmed-meshheading:11400546-Genes, BRCA1,
pubmed-meshheading:11400546-Genes, Tumor Suppressor,
pubmed-meshheading:11400546-Genetic Testing,
pubmed-meshheading:11400546-Humans,
pubmed-meshheading:11400546-Mutation,
pubmed-meshheading:11400546-Neoplasm Proteins,
pubmed-meshheading:11400546-Neoplastic Syndromes, Hereditary,
pubmed-meshheading:11400546-Ovarian Neoplasms,
pubmed-meshheading:11400546-Risk Assessment,
pubmed-meshheading:11400546-Switzerland,
pubmed-meshheading:11400546-Transcription Factors
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer.
|
|
pubmed:affiliation |
Stiftung Tumorbank Basel, Dept. Research, University Women's Clinic, Kantonsspital Basel, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
